GE HealthCare (GEHC.O) cut its revenue growth forecast for the year on Wednesday, as a freeze in China's healthcare sector due to an anti-corruption drive dragged down sales of its imaging machines and other medical equipment, sending its shares down 10%.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,